Found 4 results
↓ CSVName | Type of Offering | Accepted Date |
---|---|---|
Equilibre BioPharmaceuticals Corp.
See All Filings
|
D | 2020-11-12 12:10:33 |
Amount To Be Raised
$35,799,973
Associated Brokers / Dealers
N/A
CIK Number
0001831900
Filed Document
0001831900-20-000001
Exclusions or Exemptions
506b
Accepted Date
2020-11-12 12:10:33
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Equilibre BioPharmaceuticals Corp.
See All Filings
|
D/A | 2022-12-01 14:30:25 |
Amount To Be Raised
$6,000,002
Associated Brokers / Dealers
N/A
CIK Number
0001831900
Filed Document
0001831900-22-000002
Exclusions or Exemptions
506b
Accepted Date
2022-12-01 14:30:25
Type of Offering
D/A
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Equilibre BioPharmaceuticals Corp.
See All Filings
|
D | 2022-11-30 21:31:34 |
Amount To Be Raised
$6,000,002
Associated Brokers / Dealers
N/A
CIK Number
0001831900
Filed Document
0001831900-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-11-30 21:31:34
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Equilibre BioPharmaceuticals Corp.
See All Filings
|
D | 2022-01-20 14:25:36 |
Amount To Be Raised
$25,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001831900
Filed Document
0000947871-22-000085
Exclusions or Exemptions
506b
Accepted Date
2022-01-20 14:25:36
Type of Offering
D
Industry
Pharmaceuticals
Offering Tier
N/A
Principal Place of Business
NEW YORK
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|